Unknown

Dataset Information

0

Lipid-rich plaque density and low-density lipoprotein cholesterol in statin-treated versus statin-naive patients: a post hoc analysis of the LRP study.

ABSTRACT:

SUBMITTER: Torguson R 

PROVIDER: S-EPMC9903151 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Lipid-rich plaque density and low-density lipoprotein cholesterol in statin-treated versus statin-naïve patients: a post hoc analysis of the LRP study.

Torguson Rebecca R   Mintz Gary S GS   Zhang Cheng C   Case Brian C BC   Di Mario Carlo C   Garcia-Garcia Hector M HM   Waksman Ron R  

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20220501 1

Similar Datasets

Unknown Optimal Target Level of Low-density Lipoprotein Cholesterol for Vascular Function in Statin Naive Individuals.
| S-EPMC5566450 | biostudies-literature
Unknown Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naive acute coronary syndrome.
| S-EPMC8021554 | biostudies-literature
Unknown Oxidized low-density lipoprotein cholesterol and plaque vulnerability.
| S-EPMC12723116 | biostudies-literature
Unknown Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70.
| S-EPMC9047643 | biostudies-literature
Unknown A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation.
| S-EPMC4001802 | biostudies-literature
Unknown Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol.
| S-EPMC8635697 | biostudies-literature
Unknown Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.
| S-EPMC4746727 | biostudies-literature
Unknown Rooted in risk: genetic predisposition for low-density lipoprotein cholesterol level associates with diminished low-density lipoprotein cholesterol response to statin treatment.
| S-EPMC5558541 | biostudies-literature
Unknown Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?
| S-EPMC2921920 | biostudies-literature
Unknown Low-density lipoprotein cholesterol, statin therapy, and cerebral microbleeds: The CIRCLE study.
| S-EPMC10474226 | biostudies-literature